Atorvastatin Tablets IP 20 MG – Otovas 20 Tablets

OTOVAS 20 Tablets – Effective Lipid Control for High-Risk Patients.

OTOVAS 20 Tablets – Atorvastatin Tablets IP 20 MG is a potent statin (HMG-CoA reductase inhibitor) that effectively lowers harmful cholesterol and triglycerides while raising protective HDL cholesterol. Blocking the enzyme HMG-CoA reductase in the liver reduces cholesterol production, thereby improving lipid balance and minimizing cardiovascular risk. The 20 mg strength offers stronger lipid-lowering efficacy, making it suitable for patients who need a greater reduction in LDL levels.

Key Benefits of Atorvastatin Tablets – OTOVAS 20 Tablets
✅ Enhanced Cardiovascular Protection – Reduces the risk of heart attack, stroke, and cardiovascular deaths, especially in high-risk and post-event patients.
✅ Greater LDL Reduction – Provides stronger lipid-lowering efficacy at 20 mg, ensuring better outcomes in patients with severe dyslipidemia.
✅ Safe for Long-Term Therapy – Clinically proven safety profile even with higher doses, making it reliable for chronic use.
✅ Additional Vascular Benefits – Anti-inflammatory and antioxidant properties support overall vascular health beyond cholesterol reduction.

Recommended By Specialists:
👨‍⚕️ Cardiologists: For secondary prevention in coronary artery disease, post-MI, and stent patients requiring intensive lipid management.
👨‍⚕️ Internal Medicine Specialists / General Physicians: For patients with uncontrolled dyslipidemia or higher cardiovascular risk.
👨‍⚕️ Endocrinologists: In diabetic patients with multiple risk factors needing aggressive cholesterol control.
👨‍⚕️ Neurologists: For stroke prevention linked to atherosclerosis and high cholesterol.

INDICATIONS:
✅ Primary and secondary hypercholesterolemia
✅ Hypertriglyceridemia
✅ Cardiovascular event prevention in type 2 diabetes mellitus
✅ Secondary prevention of cardiovascular events (MI, stroke, revascularization)
✅ Patients not achieving lipid targets with lower doses